Market Insights Health Pharmacies OTC Products

Other OTC Pharmaceuticals (Pharmacies) - Germany

Germany

Revenue in the Other OTC Pharmaceuticals market is projected to reach €2.60bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.13%, resulting in a market volume of €2.75bn by 2029.
In global comparison, most revenue will be generated in the United States (€4,619.00m in 2024).
In relation to total population figures, per person revenues of €31.21 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Germany has been experiencing significant growth in recent years. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors have all contributed to this development. Customer preferences in Germany have played a key role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market. German consumers have shown a preference for self-medication and taking control of their own health. This has led to an increased demand for over-the-counter pharmaceutical products that can be purchased without a prescription. The convenience and accessibility of these products in pharmacies have made them a popular choice among German consumers. Trends in the market have also contributed to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Germany. One notable trend is the increasing focus on preventive healthcare. German consumers are becoming more proactive in managing their health and are seeking products that can help them prevent illness and maintain overall well-being. This has led to a rise in the demand for vitamins, dietary supplements, and other preventive healthcare products, which are often available over the counter in pharmacies. Another trend in the market is the growing popularity of natural and herbal remedies. German consumers are increasingly interested in alternative and complementary medicine, and are seeking out products that are perceived to be more natural and holistic. This has led to an increased demand for herbal supplements, homeopathic remedies, and other natural healthcare products, which are often found in the Other OTC Pharmaceuticals (Pharmacies) market. Local special circumstances in Germany have also played a role in the growth of the Other OTC Pharmaceuticals (Pharmacies) market. Germany has a well-developed healthcare system that emphasizes the importance of accessible and affordable healthcare for all citizens. The presence of a large number of pharmacies throughout the country ensures that consumers have easy access to over-the-counter pharmaceutical products. Additionally, the high level of trust in the German healthcare system and the strict regulations governing the sale of pharmaceutical products have contributed to the growth of the market. Underlying macroeconomic factors have further supported the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Germany. The country has a strong economy and a high standard of living, which has allowed consumers to spend more on healthcare products. Additionally, the aging population in Germany has created a greater demand for healthcare products and services, including over-the-counter pharmaceuticals. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Germany has experienced significant growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The preference for self-medication, the focus on preventive healthcare, the popularity of natural remedies, the accessibility of pharmacies, and the strong economy have all contributed to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.